Condition
Exostoses, Multiple Hereditary
Total Trials
5
Recruiting
0
Active
0
Completed
2
Success Rate
50.0%-37% vs avg
Key Insights
Highlights
Success Rate
50% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 87/100
Termination Rate
40.0%
2 terminated out of 5 trials
Success Rate
50.0%
-36.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
50%
1 of 2 completed with results
Key Signals
1 with results50% success
Data Visualizations
Phase Distribution
1Total
P 2 (1)
Trial Status
Completed2
Terminated2
Suspended1
Trial Success Rate
50.0%
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (5)
Showing 5 of 5 trials
NCT05914298CompletedPrimary
Height, Ulnar Length and Forearm Function in Multiple Hereditary Exostoses
NCT03442985Phase 2TerminatedPrimary
An Efficacy and Safety Study of Palovarotene for the Treatment of MO
NCT00474448CompletedPrimary
The Health-Related Quality of Life in Patients With Hereditary Multiple Exostoses
NCT00474331SuspendedPrimary
Gene Mutations and Orthopaedic Symptoms Correlation of Multiple Hereditary Exostoses: Multicentre Project
NCT00473850TerminatedPrimary
Establishing the Genetic Profile of Multiple Hereditary Exostoses (HME) in Families of BC
Showing all 5 trials